1
|
Taffon C, Naciu AM, Bonfiglio R, Palumbo V, Maricchiolo G, Morano V, Salducci M, Stigliano S, Palermo A, Di Matteo FM, Crescenzi A. From sampling to cellblock: The fully automated journey of cytological specimens. Diagn Cytopathol 2024; 52:611-616. [PMID: 38842251 DOI: 10.1002/dc.25366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2024] [Revised: 05/23/2024] [Accepted: 05/28/2024] [Indexed: 06/07/2024]
Abstract
In recent years, technological innovation have emerged to standardize pathology laboratory processes and reduce the handling of diagnostic samples. Among them is an automatic tissue embedding system that eliminates the need for manual activity in tissue paraffin embedding, thereby improving sample preservation. Unfortunately, this system cannot be used for cytological specimens due to the lack of an effective holder to support the procedure steps. In this study, we evaluated the performance of a commercial polymer matrix to enable and standardize the automatic paraffin embedding of cytological material from different organs and sources. Cytological samples from 40 patients were collected on the matrices and submitted for fully automatic workflow preparation, from formalin fixation until paraffin block, using the Sakura embedding system. Our results demonstrated the feasibility of the automated procedure, from loading cytological sample onto the matrix to obtaining the paraffin cellblock, thereby avoiding manual manipulation of cellular material. All samples resulted adequately processed and paraffin-embedded showing satisfactory tissue permeation by processing reagents, optimal preservation of cytoplasmic and nuclear details, and good quality of staining results on paraffin sections. Automated embedding of cytological samples eliminates the risk of lost specimens, reduces laboratory burden, standardizes procedures, increases diagnostic yield, and ultimately improves patients' management.
Collapse
Affiliation(s)
- Chiara Taffon
- Pathology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | - Anda Mihaela Naciu
- Unit of Metabolic bone and thyroid disorders, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | - Rita Bonfiglio
- Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy
| | - Valeria Palumbo
- Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy
| | - Giulia Maricchiolo
- Department of Operative Endoscopy, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | - Vittoria Morano
- Unit of Endocrine organs and neuromuscular pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | - Mauro Salducci
- Sense Organs Department, Sapienza University of Rome, Rome, Italy
| | - Serena Stigliano
- Department of Operative Endoscopy, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | - Andrea Palermo
- Unit of Metabolic bone and thyroid disorders, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | - Francesco Maria Di Matteo
- Department of Operative Endoscopy, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | - Anna Crescenzi
- Unit of Endocrine organs and neuromuscular pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
- Department of radiological, oncological, and pathological Sciences, Sapienza University of Rome, Rome, Italy
| |
Collapse
|
2
|
Mathieu MC, Suciu V, Tanguy ML, Ben Romdhane NI, Moalla S, Harguem-Zayani S, Barbe R, Balleyguier C, Conversano A, Abbaci M. Immediate Diagnosis of Breast Carcinoma on Core Needle Biopsy Using Ex Vivo Fluorescence Confocal Microscopy: Feasibility in a One-Stop Breast Clinic Workflow. Life (Basel) 2024; 14:1384. [PMID: 39598183 PMCID: PMC11595640 DOI: 10.3390/life14111384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2024] [Revised: 10/15/2024] [Accepted: 10/18/2024] [Indexed: 11/29/2024] Open
Abstract
BACKGROUND In the one-stop breast clinic setting, breast cytology traditionally provides immediate diagnosis of carcinoma. Fluorescence confocal microscopy (FCM) is an emerging optical technique enabling ex vivo analysis of breast biopsies in real-time. This study represents the first proof of concept for integrating FCM imaging into the routine workflow of breast core needle biopsies (CNB) at Gustave Roussy's one-stop breast clinic. METHODS Fifty women with breast masses underwent consecutive enrollment. Biopsies were stained with acridine orange and fast green, followed by imaging using the Vivascope 2500M-G4 (FCM). Interpretation was conducted by two pathologists in real time (PT1) or postoperatively (PT2). Concordance with definitive histology, the duration of the FCM protocol, and its impact on conventional histopathology, immunohistochemistry, and FISH analyses were evaluated. RESULTS In our study of 50 biopsies, a concordant diagnosis of malignancy was performed using FCM on the malignant cases at definitive histology in 93.5% (29/31 cases) and in 90.3% (28/31 cases) according to PT1 and PT2, respectively. When the FCM suspicious cases were added, FCM identified 100% (31/31 cases) and 96.7% (30/31 cases) of the malignant cases according to PT1 and PT2, respectively. A notable false positive case was identified as a complex sclerosing lesion. The median time for sample preparation (including tissue reception) was 5 min, while the median time for imaging acquisition with interpretation was 3 min for PT1, but 1 min required for interpretation alone by PT2. Histopathological alterations were not more prevalent in FCM-imaged biopsies compared to conventionally treated biopsies. The immunophenotyping and molecular assessment of tissue were preserved after FCM protocol. CONCLUSIONS FCM shows promise as a new histological method for the immediate diagnosis of breast carcinoma on core needle biopsies in a one-stop clinic setting, while also preserving tissue specimens for final histology.
Collapse
Affiliation(s)
- Marie-Christine Mathieu
- Department of Medical Biology and Pathology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France; (M.-C.M.)
- Surgery and Pathology Photonic Imaging Group, Gustave Roussy, 94805 Villejuif, France;
| | - Voichita Suciu
- Department of Medical Biology and Pathology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France; (M.-C.M.)
- Surgery and Pathology Photonic Imaging Group, Gustave Roussy, 94805 Villejuif, France;
| | - Marie-Laure Tanguy
- Department of Biostatistics and Epidemiology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France
- Oncostat U1018, Inserm, Université Paris-Saclay, Labeled Ligue Contre le Cancer, 94805 Villejuif, France
| | - Neila Ines Ben Romdhane
- Department of Medical Biology and Pathology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France; (M.-C.M.)
- Surgery and Pathology Photonic Imaging Group, Gustave Roussy, 94805 Villejuif, France;
| | - Salma Moalla
- Department of Radiology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France
| | - Sana Harguem-Zayani
- Department of Radiology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France
| | - Remy Barbe
- Department of Radiology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France
| | - Corinne Balleyguier
- Department of Radiology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France
| | - Angelica Conversano
- Surgery and Pathology Photonic Imaging Group, Gustave Roussy, 94805 Villejuif, France;
- Department of Breast and Plastic Surgery, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France
| | - Muriel Abbaci
- Surgery and Pathology Photonic Imaging Group, Gustave Roussy, 94805 Villejuif, France;
- UMS AMMICa 23/3655, Plateforme Imagerie et Cytométrie, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France
| |
Collapse
|
3
|
Streinu DR, Neagoe OC, Borlea A, Icma I, Derban M, Stoian D. Enhancing diagnostic precision in thyroid nodule assessment: evaluating the efficacy of a novel cell preservation technique in fine-needle aspiration cytology. Front Endocrinol (Lausanne) 2024; 15:1438063. [PMID: 39280002 PMCID: PMC11393782 DOI: 10.3389/fendo.2024.1438063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/24/2024] [Accepted: 08/05/2024] [Indexed: 09/18/2024] Open
Abstract
Objectives This study aimed to evaluate the effectiveness of thyroid fine needle aspiration cytology (FNAC) using a novel-cell preserving matrix called Cytomatrix in improving diagnostic accuracy for thyroid nodules. Materials and methods Fifty patients undergoing thyroidectomy were enrolled and FNAC was performed on the excised thyroid glands, with the collected sample being placed on the Cytomatrix. The results were compared with histopathological analysis, and diagnostic performance was assessed statistically. Results Cytomatrix demonstrated an accuracy of 96%, sensitivity of 84.61%, and specificity of 100%. Concordance between cytological and histopathological findings highlighted Cytomatrix's potential to enhance thyroid FNAC accuracy. Conclusion FNAC using Cytomatrix shows promise in improving diagnostic accuracy for thyroid nodules. Its application, marked by faster processing and efficient resource utilization, coupled with the preservation of cellular architecture, holds considerable potential in enhancing cytological diagnosis, thus optimizing patient management strategies.
Collapse
Affiliation(s)
- Diana-Raluca Streinu
- Department of Doctoral Studies, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
- Center of Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
- First Surgery Clinic, “Pius Brinzeu” Clinical Emergency Hospital, Timisoara, Romania
| | - Octavian Constantin Neagoe
- Second Clinic of General Surgery and Surgical Oncology, Timisoara Municipal Emergency Clinical Hospital, Timisoara, Romania
- Center for Advanced Ultrasound Evaluation, Dr. D Medical Center, Timisoara, Romania
| | - Andreea Borlea
- Center of Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
- Center for Advanced Ultrasound Evaluation, Dr. D Medical Center, Timisoara, Romania
- 2nd Department of Internal Medicine, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Ion Icma
- First Surgery Clinic, “Pius Brinzeu” Clinical Emergency Hospital, Timisoara, Romania
| | - Mihnea Derban
- Department of Pathology, CF Clinical Hospital, Timisoara, Romania
| | - Dana Stoian
- Center of Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
- Center for Advanced Ultrasound Evaluation, Dr. D Medical Center, Timisoara, Romania
- 2nd Department of Internal Medicine, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| |
Collapse
|
4
|
Deniz MS, Guler BY. Assessment of ChatGPT's adherence to ETA-thyroid nodule management guideline over two different time intervals 14 days apart: in binary and multiple-choice queries. Endocrine 2024; 85:794-802. [PMID: 38489133 DOI: 10.1007/s12020-024-03750-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2024] [Accepted: 02/15/2024] [Indexed: 03/17/2024]
Abstract
OBJECTIVE Artificial intelligence (AI) has significant potential in healthcare, particularly in providing decision-support in specialized domains like thyroid nodule management. This study assesses the effectiveness of ChatGPT-v4, an advanced AI model, in aligning with the European Thyroid Association (ETA) - 2023 guidelines. METHODS The study utilized a structured questionnaire comprising 100 questions, divided into true/false and multiple-choice formats, reflecting real-world clinical scenarios in thyroid nodule management. These questions encompassed diagnostic criteria, treatment options, follow-up protocols, and patient counseling. ChatGPT response was evaluated for accuracy, consistency, and comprehensiveness using a six-point Likert scale. The assessment occurred initially and was repeated after 14 days. RESULTS In the binary queries, the AI model showed an ability to correct some initially incorrect responses. However, there was a noticeable regression in certain responses. 8 of the 11 previously non-compliant responses remained unchanged, while 3 non-compliant responses were rectified. Conversely, 6 initially compliant answers transitioned to non-compliance after 14 days. In multiple-choice queries, the AI's performance was more consistent. A majority of the responses, 43 (86% of the total), were initially correct and maintained their correctness upon re-assessment. However, 4 responses that were initially incorrect remained unchanged, and 3 correct responses shifted to non-compliance over time. CONCLUSION ChatGPT exhibited improving potential as a clinical support tool in thyroid nodule management altgouh it showed varied performance for binary and multiple-choice questions. CLINICAL TRIAL REGISTRATION N/A.
Collapse
Affiliation(s)
- Muzaffer Serdar Deniz
- Department of Endocrinology, Sincan Education and Research Hospital, Ankara, Turkey.
| | | |
Collapse
|
5
|
Kamm M, Hildebrandt F, Titze B, Höink AJ, Vorwerk H, Sievert KD, Groetzner J, Titze U. Ex Vivo Fluorescence Confocal Microscopy for Intraoperative Examinations of Lung Tumors as Alternative to Frozen Sections-A Proof-of-Concept Study. Cancers (Basel) 2024; 16:2221. [PMID: 38927926 PMCID: PMC11202023 DOI: 10.3390/cancers16122221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Revised: 06/09/2024] [Accepted: 06/12/2024] [Indexed: 06/28/2024] Open
Abstract
BACKGROUND Intraoperative frozen sections (FS) are frequently used to establish the diagnosis of lung cancer when preoperative examinations are not conclusive. The downside of FS is its resource-intensive nature and the risk of tissue depletion when small lesions are assessed. Ex vivo fluorescence confocal microscopy (FCM) is a novel microimaging method for loss-free examinations of native materials. We tested its suitability for the intraoperative diagnosis of lung tumors. METHODS Samples from 59 lung resection specimens containing 45 carcinomas were examined in the FCM. The diagnostic performance in the evaluation of malignancy and histological typing of lung tumors was evaluated in comparison with FS and the final diagnosis. RESULTS A total of 44/45 (98%) carcinomas were correctly identified as malignant in the FCM. A total of 33/44 (75%) carcinomas were correctly subtyped, which was comparable with the results of FS and conventional histology. Our tests documented the excellent visualization of cytological features of normal tissues and tumors. Compared to FS, FCM was technically less demanding and less personnel intensive. CONCLUSIONS The ex vivo FCM is a fast, effective, and safe method for diagnosing and subtyping lung cancer and is, therefore, a promising alternative to FS. The method preserves the tissue without loss for subsequent examinations, which is an advantage in the diagnosis of small tumors and for biobanking.
Collapse
Affiliation(s)
- Max Kamm
- Department of Pathology, Medical School and University Medical Center OWL, Klinikum Lippe, Lung Cancer Center Lippe, Bielefeld University, 32756 Detmold, Germany; (M.K.); (F.H.); (B.T.)
| | - Felix Hildebrandt
- Department of Pathology, Medical School and University Medical Center OWL, Klinikum Lippe, Lung Cancer Center Lippe, Bielefeld University, 32756 Detmold, Germany; (M.K.); (F.H.); (B.T.)
| | - Barbara Titze
- Department of Pathology, Medical School and University Medical Center OWL, Klinikum Lippe, Lung Cancer Center Lippe, Bielefeld University, 32756 Detmold, Germany; (M.K.); (F.H.); (B.T.)
| | - Anna Janina Höink
- Department of Diagnostic and Interventional Radiology, Medical School and University Medical Center OWL, Klinikum Lippe, Lung Cancer Center Lippe, Bielefeld University, 32756 Detmold, Germany;
| | - Hagen Vorwerk
- Department of Pneumology, Respiratory and Sleep Medicine, Klinikum Lippe Lemgo, Lung Cancer Center Lippe, 32657 Lemgo, Germany;
| | - Karl-Dietrich Sievert
- Department of Urology, Medical School and University Medical Center OWL, Klinikum Lippe, Bielefeld University, 32756 Detmold, Germany;
| | - Jan Groetzner
- Department of Thoracic Surgery, Klinikum Lippe Lemgo, Lung Cancer Center Lippe, 32657 Lemgo, Germany;
| | - Ulf Titze
- Department of Pathology, Medical School and University Medical Center OWL, Klinikum Lippe, Lung Cancer Center Lippe, Bielefeld University, 32756 Detmold, Germany; (M.K.); (F.H.); (B.T.)
| |
Collapse
|